Treatment of cytomegalovirus retinitis with ganciclovir (9-[2-hydroxy-1-(hydroxy methy1) ethoxymethyl] guanine (BW B759U)) Academic Article uri icon

Overview

MeSH Major

  • Multiple Sclerosis

abstract

  • Six patients (11 eyes) with virologically confirmed cytomegalovirus (CMV) retinitis involving the posterior pole of the eye were treated with a new drug, ganciclovir. Treatment with intravenous ganciclovir consistently halted progression of retinitis and produced improvement in measures of visual function. However, within three weeks after cessation of therapy renewed CMV activity and worsening of visual function were observed in most cases. Maintenance therapy with ganciclovir extended the period of remission from CMV retinitis.

publication date

  • January 1988

Research

keywords

  • Academic Article

Identity

Digital Object Identifier (DOI)

  • 10.1136/bjo.72.7.525

Additional Document Info

start page

  • 525

end page

  • 9

volume

  • 72

number

  • 7